Importantly, it also suggests that either pharmacological modulation of Kir6.2-KATP channels or dietary modifications that include low-carbohydrate diets hold therapeutic promise for patients with diabetes and prediabetes to help reduce the risk of developing AD. This evidence concerns the gene KCNJ11 and Alzheimer disease.